Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zoetis Inc ZTS

Healthcare
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).


NYSE:ZTS - Post by User

Zoetis Inc > Elanco poses a real threat here
Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Post by TrickyGuyon Mar 04, 2024 3:44pm
94 Views
Post# 35914132

Elanco poses a real threat here

Elanco poses a real threat hereElanco Animal Health is #2 in animal pharmaceuticals.

Zoetis has 15 Blockbuster drugs (>$100 million in sales) and has been a stock market darling.
#1 in Companion animals (mostly dogs and cats) plus Farm animals. Strong relationship with vets.
 
Elanco (ELAN symbol) has 9 Blockbuster drugs plus 6 potential Blockbuster drugs in the US by 2025!
New drugs focus on Pet parasites, dermatology and pain; Farm – livestock sustainability [emissions]
Elanco was a spin off of Eli Lilly's animal business plus Bayer's animal pharma business.
$4.4 Billion in Sales. 55% outside US (20% Companion, 35% Farm), 90+ countries
45% US breakdown: 28% Companion, 17% Farm.

Disclosure: I don't own either at these prices.
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities